Editorial Comment on: Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes by Metcalfe et al

J Endourol. 2017 Sep;31(9):954-955. doi: 10.1089/end.2017.0536.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adjuvants, Immunologic
  • Carcinoma, Transitional Cell*
  • Chemotherapy, Adjuvant
  • Humans
  • Kidney Neoplasms
  • Mitomycin*
  • Ureteral Neoplasms
  • Urologic Neoplasms

Substances

  • Adjuvants, Immunologic
  • Mitomycin